131 related articles for article (PubMed ID: 15543378)
21. Usefulness of Non-magnifying Narrow Band Imaging in EVIS EXERA III Video Systems and High-Definition Endoscopes to Diagnose Dysplasia in Barrett's Esophagus Using the Barrett International NBI Group (BING) Classification.
Nogales O; Caballero-Marcos A; Clemente-Sánchez A; García-Lledó J; Pérez-Carazo L; Merino B; Carbonell C; López-Ibáñez M; González-Asanza C
Dig Dis Sci; 2017 Oct; 62(10):2840-2846. PubMed ID: 28432477
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus with enhanced magnification endoscopy.
Mayinger B; Oezturk Y; Stolte M; Faller G; Benninger J; Schwab D; Maiss J; Hahn EG; Muehldorfer S
Scand J Gastroenterol; 2006 Mar; 41(3):349-56. PubMed ID: 16497625
[TBL] [Abstract][Full Text] [Related]
23. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.
Reid BJ; Haggitt RC; Rubin CE; Roth G; Surawicz CM; Van Belle G; Lewin K; Weinstein WM; Antonioli DA; Goldman H
Hum Pathol; 1988 Feb; 19(2):166-78. PubMed ID: 3343032
[TBL] [Abstract][Full Text] [Related]
24. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
Geisinger KR; Teot LA; Richter JE
Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
[TBL] [Abstract][Full Text] [Related]
25. Inter-Observer Agreement among Pathologists Using Wide-Area Transepithelial Sampling With Computer-Assisted Analysis in Patients With Barrett's Esophagus.
Vennalaganti PR; Naag Kanakadandi V; Gross SA; Parasa S; Wang KK; Gupta N; Sharma P
Am J Gastroenterol; 2015 Sep; 110(9):1257-60. PubMed ID: 25916227
[TBL] [Abstract][Full Text] [Related]
26. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
27. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.
Ormsby AH; Petras RE; Henricks WH; Rice TW; Rybicki LA; Richter JE; Goldblum JR
Gut; 2002 Nov; 51(5):671-6. PubMed ID: 12377805
[TBL] [Abstract][Full Text] [Related]
28. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
[TBL] [Abstract][Full Text] [Related]
31. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus.
Niepsuj K; Niepsuj G; Cebula W; Zieleźnik W; Adamek M; Sielańczyk A; Adamczyk J; Kurek J; Sieroń A
Gastrointest Endosc; 2003 Nov; 58(5):715-9. PubMed ID: 14595307
[TBL] [Abstract][Full Text] [Related]
32. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
33. Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices.
Davison JM; Shah MB; Deitrick C; Chennat J; Fasanella KE; McGrath K
Gastrointest Endosc; 2018 Nov; 88(5):807-815.e2. PubMed ID: 29944863
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
35. Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.
Singh R; Anagnostopoulos GK; Yao K; Karageorgiou H; Fortun PJ; Shonde A; Garsed K; Kaye PV; Hawkey CJ; Ragunath K
Endoscopy; 2008 Jun; 40(6):457-63. PubMed ID: 18459090
[TBL] [Abstract][Full Text] [Related]
36. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus.
Evans JA; Poneros JM; Bouma BE; Bressner J; Halpern EF; Shishkov M; Lauwers GY; Mino-Kenudson M; Nishioka NS; Tearney GJ
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):38-43. PubMed ID: 16431303
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: an endoscopic study.
Khan S; Do KA; Kuhnert P; Pillay SP; Papadimos D; Conrad R; Jass JR
Pathology; 1998 May; 30(2):136-40. PubMed ID: 9643490
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of cytopathology and histology in the evaluation of Barrett's esophagus in a community hospital.
Alexander JA; Jones SM; Smith CJ; Doull JA; Gietzen TH; Rathgaber SW
Gastrointest Endosc; 1997 Oct; 46(4):318-20. PubMed ID: 9351033
[TBL] [Abstract][Full Text] [Related]
39. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
40. Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible.
Kaye PV; Ilyas M; Soomro I; Haider SA; Atwal G; Menon S; Gill S; Richards C; Harrison R; West K; Ragunath K
Histopathology; 2016 Sep; 69(3):431-40. PubMed ID: 26918780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
